Suppr超能文献

玻璃体积血-病因、诊断和治疗。

Vitreous hemorrhage - Causes, diagnosis, and management.

机构信息

Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Anant Bajaj Retina Institute, LVPEI, Hyderabad, Telangana, India.

出版信息

Indian J Ophthalmol. 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22.

Abstract

Vitreous hemorrhage is associated with a myriad of conditions such as proliferative diabetic retinopathy, proliferative retinopathy following vascular occlusion and vasculitis, trauma, retinal breaks, and posterior vitreous detachment without retinal break. Multiple pathological mechanisms are associated with development of vitreous hemorrhage such as disruption of abnormal vessels, normal vessels, and extension of blood from an adjacent source. The diagnosis of vitreous hemorrhage requires a thorough history taking and clinical examination including investigations such as ultra-sonography, which help decide the appropriate time for intervention. The prognosis of vitreous hemorrhage depends on the underlying cause. Treatment options include observation, laser photo-coagulation, cryotherapy, intravitreal injections of anti-vascular endothelial growth factor, and surgery. Pars plana vitrectomy remains the cornerstone of management. Complications of vitreous hemorrhage include glaucoma (ghost cell glaucoma, hemosiderotic glaucoma), proliferative vitreoretinopathy, and hemosiderosis bulbi.

摘要

玻璃体积血与多种疾病相关,如增殖性糖尿病视网膜病变、血管阻塞和脉管炎后的增殖性视网膜病变、创伤、视网膜裂孔以及无视网膜裂孔的后玻璃体脱离。多种病理机制与玻璃体积血的发生相关,如异常血管、正常血管的破裂以及来自邻近部位的血液延伸。玻璃体积血的诊断需要详细的病史采集和临床检查,包括超声等检查,这些检查有助于确定干预的适当时机。玻璃体积血的预后取决于潜在病因。治疗选择包括观察、激光光凝、冷冻疗法、眼内注射抗血管内皮生长因子以及手术。玻璃体切割术仍然是治疗的基石。玻璃体积血的并发症包括青光眼(鬼影细胞性青光眼、含铁血黄素性青光眼)、增殖性玻璃体视网膜病变和眼铁质沉着症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7975/10155538/01dca9194370/IJO-71-28-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验